Search research articles
Contact Us
Filters
Showing results (61-70 of 189) with videos related to
Page
of 19
Sort By:
Expert Opinion on Biological Therapy
|
December 21, 2018
Clinical SLEDAI-2K zero may be a pragmatic outcome measure in SLE studies
Ioannis Parodis, Sharzad Emamikia, Alvaro Gomez, et al.
Rheumatology Advances in Practice
|
April 21, 2025
Predicting EQ-5D full health state in systemic lupus erythematosus using machine learning algorithms
João Botto, Nursen Cetrez, Dionysis Nikolopoulos, et al.
Lupus Science & Medicine
|
February 26, 2025
Development and evaluation of a Register-Based Organ Damage Index in systemic lupus erythematosus: a nationwide, population-based study from Sweden
Alvaro Gomez, Ioannis Parodis, Muna Saleh, et al.
Journal of Patient-Reported Outcomes
|
February 7, 2026
The value of EQ-5D-3L and EQ VAS as a patient-reported outcome measure for patients with ankylosing spondylitis in routine healthcare: an evaluation of construct validity and responsiveness based on the Swedish Rheumatology Quality Register
Kinza Degerlund-Maldi, Malin Regardt, Camilla Nystrand Länsman, et al.
Rheumatology (Oxford, England)
|
March 14, 2025
Belimumab efficacy in mucocutaneous lupus erythematosus: a large post-hoc analysis from five phase III clinical trials
Giorgia Grosso, Nefeli Giannopoulou, Alexander Tsoi, et al.
Expert Review of Clinical Immunology
|
February 4, 2026
Old and New autoantibodies in systemic lupus erythematosus
Ioannis Parodis, Dionysis Nikolopoulos, André Brylid, et al.
Nature Reviews. Disease Primers
|
January 25, 2020
Lupus nephritis
Hans-Joachim Anders, Ramesh Saxena, Ming-Hui Zhao, et al.
Nature Reviews. Rheumatology
|
November 12, 2021
Differentiating between UCTD and early-stage SLE: from definitions to clinical approach
Savino Sciascia, Dario Roccatello, Massimo Radin, et al.
International Journal of Molecular Sciences
|
November 26, 2022
B Cell Kinetics upon Therapy Commencement for Active Extrarenal Systemic Lupus Erythematosus in Relation to Development of Renal Flares: Results from Three Phase III Clinical Trials of Belimumab
Ioannis Parodis, Alvaro Gomez, Julius Lindblom, et al.
Lupus Science & Medicine
|
July 22, 2021
Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study
Isak Samuelsson, Ioannis Parodis, Iva Gunnarsson, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 189) with videos related to
Sort By:
Page
of 19
Expert Opinion on Biological Therapy
|
December 21, 2018
Clinical SLEDAI-2K zero may be a pragmatic outcome measure in SLE studies
Ioannis Parodis, Sharzad Emamikia, Alvaro Gomez, et al.
Rheumatology Advances in Practice
|
April 21, 2025
Predicting EQ-5D full health state in systemic lupus erythematosus using machine learning algorithms
João Botto, Nursen Cetrez, Dionysis Nikolopoulos, et al.
Lupus Science & Medicine
|
February 26, 2025
Development and evaluation of a Register-Based Organ Damage Index in systemic lupus erythematosus: a nationwide, population-based study from Sweden
Alvaro Gomez, Ioannis Parodis, Muna Saleh, et al.
Journal of Patient-Reported Outcomes
|
February 7, 2026
The value of EQ-5D-3L and EQ VAS as a patient-reported outcome measure for patients with ankylosing spondylitis in routine healthcare: an evaluation of construct validity and responsiveness based on the Swedish Rheumatology Quality Register
Kinza Degerlund-Maldi, Malin Regardt, Camilla Nystrand Länsman, et al.
Rheumatology (Oxford, England)
|
March 14, 2025
Belimumab efficacy in mucocutaneous lupus erythematosus: a large post-hoc analysis from five phase III clinical trials
Giorgia Grosso, Nefeli Giannopoulou, Alexander Tsoi, et al.
Expert Review of Clinical Immunology
|
February 4, 2026
Old and New autoantibodies in systemic lupus erythematosus
Ioannis Parodis, Dionysis Nikolopoulos, André Brylid, et al.
Nature Reviews. Disease Primers
|
January 25, 2020
Lupus nephritis
Hans-Joachim Anders, Ramesh Saxena, Ming-Hui Zhao, et al.
Nature Reviews. Rheumatology
|
November 12, 2021
Differentiating between UCTD and early-stage SLE: from definitions to clinical approach
Savino Sciascia, Dario Roccatello, Massimo Radin, et al.
International Journal of Molecular Sciences
|
November 26, 2022
B Cell Kinetics upon Therapy Commencement for Active Extrarenal Systemic Lupus Erythematosus in Relation to Development of Renal Flares: Results from Three Phase III Clinical Trials of Belimumab
Ioannis Parodis, Alvaro Gomez, Julius Lindblom, et al.
Lupus Science & Medicine
|
July 22, 2021
Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study
Isak Samuelsson, Ioannis Parodis, Iva Gunnarsson, et al.
Page
of 19